p53-defective tumors with a functional apoptosome-mediated pathway: A new therapeutic target

Journal of the National Cancer Institute

Volumn 97, Issue 10, 2005, Pages 765-777

  Mashima, Tetsuo ^a   Oh hara, Tomoko ^a   Sato, Shigeo ^a   Mochizuki, Mikiko ^a   Sugimoto, Yoshikazu ^a,e   Yamazaki, Kanami ^a   Hamada, Jun Ichi ^b   Tada, Mitsuhiro ^b   Moriuchi, Tetsuya ^b   Ishikawa, Yuichi ^c   Kato, Yo ^c   Tomoda, Hiroshi ^d   Yamori, Takao ^a   Tsuruo, Takashi ^a,f  

^a CANCER CHEMOTHERAPY CENTER   (Japan)

^b HOKKAIDO UNIVERSITY   (Japan)

^c CANCER INSTITUTE   (Japan)

^d KITASATO UNIVERSITY   (Japan)

^e KEIO UNIVERSITY   (Japan)

^f UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

APOPTOSOME; CARDIOLIPIN; CASPASE; CASPASE 9; CYTOCHROME C; ENZYME INHIBITOR; LONG CHAIN FATTY ACID COENZYME A LIGASE; PROTEIN P53; TRIACSIN C; UNCLASSIFIED DRUG; ACSL5 PROTEIN, HUMAN; ANTINEOPLASTIC AGENT; APAF1 PROTEIN, HUMAN; APAF1 PROTEIN, MOUSE; APOPTOSIS INDUCING FACTOR; APOPTOTIC PROTEASE ACTIVATING FACTOR 1; FLAVOPROTEIN; MEMBRANE PROTEIN; PDCD8 PROTEIN, HUMAN; PDCD8 PROTEIN, MOUSE; PROTEIN; SMALL INTERFERING RNA; TRIAZENE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INHIBITION; CELL DEATH; CELL SURVIVAL; CONCENTRATION RESPONSE; DNA SEQUENCE; DRUG TARGETING; ENZYME ACTIVATION; ENZYME ACTIVITY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MOUSE; MOUSE STRAIN; NONHUMAN; NUDE MOUSE; PHOSPHOLIPID BLOOD LEVEL; PRIORITY JOURNAL; SEQUENCE ANALYSIS; STUDENT T TEST; TUMOR CELL LINE; TUMOR GROWTH; TUMOR VOLUME; TUMOR XENOGRAFT; ANIMAL; APOPTOSIS; BLOOD; BRAIN TUMOR; BREAST TUMOR; COLON TUMOR; DRUG ANTAGONISM; DRUG EFFECT; ENZYMOLOGY; EXPERIMENTAL NEOPLASM; FEMALE; GENE TRANSFER; LUNG TUMOR; METABOLISM; MITOCHONDRION; STOMACH TUMOR; WESTERN BLOTTING; XENOGRAFT;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; APOPTOSIS INDUCING FACTOR; APOPTOTIC PROTEASE-ACTIVATING FACTOR 1; BLOTTING, WESTERN; BRAIN NEOPLASMS; BREAST NEOPLASMS; CARDIOLIPINS; CASPASES; COENZYME A LIGASES; COLONIC NEOPLASMS; CYTOCHROMES C; ENZYME ACTIVATION; ENZYME INHIBITORS; FEMALE; FLAVOPROTEINS; GENE TRANSFER TECHNIQUES; HUMANS; LUNG NEOPLASMS; MEMBRANE PROTEINS; MICE; MICE, NUDE; MITOCHONDRIA; NEOPLASMS, EXPERIMENTAL; PROTEINS; RNA, SMALL INTERFERING; SEQUENCE ANALYSIS, DNA; STOMACH NEOPLASMS; TRANSFECTION; TRANSPLANTATION, HETEROLOGOUS; TRIAZENES; TUMOR SUPPRESSOR PROTEIN P53;

EID: 20544432048     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/dji133     Document Type: Article

References (42)

1. Strasser A, O'Connor L, Dixit, V. Apoptosis signaling. Annu Rev Biochem 2000;69:217-45.
2. Budihardjo I, Oliver H, Lutter M, Luo X, Wang X. Biochemical pathways of caspase activation during apoptosis. Annu Rev Cell Dev Biol 1999;15: 269-90.
3. Fridman JS, Lowe SW. Control of apoptosis by p53. Oncogene 2003;22:9030-40.
4. Fearnhead HO, Rodriguez J, Govek EE, Guo W, Kobayashi R, Hannon G, et al. Oncogene-dependent apoptosis is mediated by caspase-9. Proc Natl Acad Sci U S A 1998;95:13664-9.
5. Moroni MC, Hickman ES, Denchi EL, Caprara G, Colli E, Cecconi F, et al. Apaf-1 is a transcriptional target for E2F and p53. Nat Cell Biol 2001;3: 552-8.
6. Nahle Z, Polakoff J, Davuluri RV, McCurrach ME, Jacobson MD, Narita M, et al. Direct coupling of the cell cycle and cell death machinery by E2F. Nat Cell Biol 2002;4:859-64.
7. Vakkala M, Paakko P, Soini Y. Expression of caspases 3, 6 and 8 is increased in parallel with apoptosis and histological aggressiveness of the breast lesion. Br J Cancer 1999;81:592-99.
8. Krepela E, Prochazka J, Liul X, Fiala P, Kinkor Z. Increased expression of Apaf-1 and procaspase-3 and the functionality of intrinsic apoptosis apparatus in non-small-cell lung carcinoma. Biol Chem 2004;385:153-68.
9. Mendelsohn AR, Hamer JD, Wang ZB, Brent R. Cyclin D3 activates Caspase 2, connecting cell proliferation with cell death. Proc Natl Acad Sci U S A 2002;99:6871-6.
10. Nguyen JT, Wells JA. Direct activation of the apoptosis machinery as a mechanism to target cancer cells. Proc Natl Acad Sci U S A 2003;100:7533-8.
11. Fantin VR, Berardi MJ, Scorrano L, Korsmeyer SJ, Leder PA. Novel mitochondriotoxic small molecule that selectively inhibits tumor cell growth. Cancer Cell 2002;2:29-42.
12. Johnstone RW, Ruefli AA, Lowe SW. Apoptosis: a link between cancer genetics and chemotherapy. Cell 2002;108:153-64.
13. Tsuruo T, Naito M, Tomida A, Fujita N, Mashima T, Sakamoto H, Haga N. Molecular targeting therapy of cancer: drug resistance, apoptosis and survival signal. Cancer Sci 2003;94:15-21.
14. Schmitt CA, Fridman JS, Yang M, Baranov E, Hoffman RM, Lowe SW. Dissecting p53 tumor suppressor functions in vivo. Cancer Cell 2002;1:289-98.
15. Scott CL, Schuler M, Marsden VS, Egle A, Pellegrini M, Nesic D, et al. Apaf-1 and caspase-9 do not act as tumor suppressors in myc-induced lymphomagenesis or mouse embryo fibroblast transformation. J Cell Biol 2004;164:89-96.
16. Yang L, Mashima T, Sato S, Mochizuki M, Sakamoto H, Yamori T, et al. Predominant suppression of apoptosome by inhibitor of apoptosis protein in non-small-cell lung cancer H460 cells: therapeutic effect of a novel polyarginine-conjugated Smac peptide. Cancer Res 2003;63:831-7.
17. Iverson SL, Orrenius S. The cardiolipin-cytochrome c interaction and the mitochondrial regulation of apoptosis. Arch Biochem Biophys 2004;423:37-46.
18. Kim TH, Zhao Y, Ding WX, Shin JN, He X, Seo YW, et al. Bid-cardiolipin interaction at mitochondrial contact site contributes to mitochondrial cristae reorganization and cytochrome C release. Mol Biol Cell 2004;15:3061-72.
19. Tomoda H, Igarashi K, Omura S. Inhibition of acyl-CoA synthetase by triacsins. Biochim Biophys Acta 1987;921:595-8.
20. O'Connor PM, Jackman J, Bae I, Myers TG, Fan S, Mutoh M, et al. Characterization of the p53 tumor suppressor pathway in cell lines of the National Cancer Institute anticancer drug screen and correlations with the growth-inhibitory potency of 123 anticancer agents. Cancer Res 1997;57:4285-300.
21. Sakamoto H, Mashima T, Yamamoto K, Tsuruo T. Modulation of heat-shock protein 27 (Hsp27) anti-apoptotic activity by methylglyoxal modification. J Biol Chem 2002;277:45770-5.
22. Jia LQ, Osada M, Ishioka C, Gamo M, Ikawa S, Suzuki T, et al. Screening the p53 status of human cell lines using a yeast functional assay. Mol Carcinog 1997;19:243-53.
23. Takahashi M, Tonoki H, Tada M, Kashiwazaki H, Furuuchi K, Hamada J, et al. Distinct prognostic values of p53 mutations and loss of estrogen receptor and their cumulative effect in primary breast cancers. Int J Cancer 2000;89:92-9.
24. Yamori T. Panel of human cancer cell lines provides valuable database for drug discovery and bioinformatics. Cancer Chemother Pharmacol 2003;52:S74-9.
25. Yamori T, Matsunaga A, Sato S, Yamazaki K, Komi A, Ishizu. K, et al. Potent antitumor activity of MS-247, a novel DNA minor groove binder, evaluated by an in vitro and in vivo human cancer cell line panel. Cancer Res 1999;59:4042-9.
26. Kage K, Tsukahara S, Sugiyama T, Asada S, Ishikawa E, Tsuruo T, et al. Dominant-negative inhibition of breast cancer resistance protein as drug efflux pump through the inhibition of S-S dependent homodimerization. Int J Cancer 2002;97:626-30.
27. Mashima T, Naito M, Tsuruo T. Caspase-mediated cleavage of cytoskeletal actin plays a positive role in the process of morphological apoptosis. Oncogene 1999;18:2423-30.
28. Banis RJ, Tove SB. Solubilization of a long chain fatty acyl-CoA synthetase from chicken adipose tissue microsomes. Biochim Biophys Acta 1974;348:210-20.
29. Hardy S, El-Assaad W, Przybytkowski E, Joly E, Prentki M, Langelier Y. Saturated fatty acid-induced apoptosis in MDA-MB-231 breast cancer cells. A role for cardiolipin. J Biol Chem 2003;278:31861-70.
30. Shimizu S, Tsujimoto Y. Proapoptotic BH3-only Bcl-2 family members induce cytochrome c release, but not mitochondrial membrane potential loss, and do not directly modulate voltage-dependent anion channel activity. Proc Natl Acad Sci U S A 2000;97:577-82.
31. Yamashita Y, Kumabe T, Cho YY, Watanabe M, Kawagishi J, Yoshimoto T, et al. Fatty acid induced glioma cell growth is mediated by the acyl-CoA synthetase 5 gene located on chromosome 10q25.1-q25.2, a region frequently deleted in malignant gliomas. Oncogene 2000;19:5919-25.
32. Cao Y, Dave KB, Doan TP, Prescott SM. Fatty acid CoA ligase 4 is up-regulated in colon adenocarcinoma. Cancer Res 2001;61:8429-34.
33. Coleman RA, Lewin TM, Van Horn CG, Gonzalez-Baro MR. Do long-chain acyl-CoA synthetases regulate fatty acid entry into synthetic versus degradative pathways? J Nutr 2002;132:2123-6.
34. Kuwana T, Mackey MR, Perkins G, Ellisman MH, Latterich M, Schneiter R, et al. Bid, Bax, and lipids cooperate to form supramolecular openings in the outer mitochondrial membrane. Cell 2002;111:331-42.
35. Iverson SL, Enoksson M, Gogvadze V, Ott M, Orrenius S. Cardiolipin is not required for Bax-mediated cytochrome c release from yeast mitochondria. J Biol Chem 2004;279:1100-7.
36. Marzo I, Brenner C, Zamzami N, Jurgensmeier JM, Susin SA, Vieira HL, et al. Bax and adenine nucleotide translocator cooperate in the mitochondrial control of apoptosis. Science 1998;281:2027-31.
37. Woldegiorgis G, Yousufzai SY, Shrago E. Studies on the interaction of palmitoyl coenzyme A with the adenine nucleotide translocase. J Biol Chem 1982;257:14783-7.
38. Kokoszka JE, Waymire KG, Levy SE, Sligh JE, Cai J, Jones DP, et al. The ADP/ATP translocator is not essential for the mitochondrial permeability transition pore. Nature 2004;427:461-5.
39. Woldegiorgis G, Lawrence J, Ruoho A, Duff T, Shrago E. Photoaffinity labeling of mitochondrial proteins with 2-azido [32P]palmitoyl CoA. FEBS Lett 1995;364:143-6.
40. Arai T, Kawakami Y, Matsushima T, Okuda Y, Yamashita K. Intracellular fatty acid downregulates ob gene expression in 3T3-L1 adipocytes. Biochem Biophys Res Commun 2002;297:1291-6.
41. Wieckowski MR, Brdiczka D, Wojtczak L. Long-chain fatty acids promote opening of the reconstituted mitochondrial permeability transition pore. FEBS Lett 2000;484:61-4.
42. Scorrano L, Penzo D, Petronilli V, Pagano F, Bernardi P. Arachidonic acid causes cell death through the mitochondrial permeability transition. Implications for tumor necrosis factor-alpha apoptotic signaling. J Biol Chem 2001;276:12035-40.